Absence of the CXCR4 antagonist EPI‑X4 from pharmaceutical human serum albumin preparations
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: Journal of Translational Medicine ; 19 (2021). - Art.-Nr. 190. - eISSN 1479-5876
- Keyword
-
Chemokinrezpetor
Serumalbumine
- Event
-
Veröffentlichung
- (where)
-
Ulm
- (who)
-
Universität Ulm
- (when)
-
2021
- Creator
- DOI
-
10.18725/OPARU-41724
- URN
-
urn:nbn:de:bsz:289-oparu-41800-0
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:51 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Gilg, Andrea
- Harms, Mirja
- Olari, Lia‑Raluca
- Urbanowitz, Ann-Kathrin
- Bönig, Halvard
- Münch, Jan
- Universität Ulm
Time of origin
- 2021
Other Objects (12)
Discovery and characterization of an endogenous CXCR4 antagonist
Targeting of CXCR4 by the naturally occurring CXCR4 antagonist EPI-X4 in waldenström’s macroglobulinemia
The influence of various aminoglycoside preparations on bilirubin/albumin binding
Establishment of an ELISA to detect the CXCR4 antagonist hSA (408-423) and characterization of CXCR4 mutants associedet with WHIM syndrome
Antagonist
The novel CXCR4 antagonist POL5551 mobilizes hematopoietic stem and progenitor cells with greater efficiency than Plerixafor
The CXCR4 antagonist POL5551 is equally effective as sirolimus in reducing neointima formation without re-endothelialisation
Albumin
The CXCR4 antagonist plerixafor (AMD3100) promotes proliferation of Ewing sarcoma cell lines in vitro and activates receptor tyrosine kinase signaling
Albumin-Mattpapier
Absence
Dola Purnami preparations
Discovery and characterization of an endogenous CXCR4 antagonist
Targeting of CXCR4 by the naturally occurring CXCR4 antagonist EPI-X4 in waldenström’s macroglobulinemia
The influence of various aminoglycoside preparations on bilirubin/albumin binding
Establishment of an ELISA to detect the CXCR4 antagonist hSA (408-423) and characterization of CXCR4 mutants associedet with WHIM syndrome
Antagonist
The novel CXCR4 antagonist POL5551 mobilizes hematopoietic stem and progenitor cells with greater efficiency than Plerixafor
The CXCR4 antagonist POL5551 is equally effective as sirolimus in reducing neointima formation without re-endothelialisation
Albumin
The CXCR4 antagonist plerixafor (AMD3100) promotes proliferation of Ewing sarcoma cell lines in vitro and activates receptor tyrosine kinase signaling
Albumin-Mattpapier
Absence
Dola Purnami preparations
Discovery and characterization of an endogenous CXCR4 antagonist
Targeting of CXCR4 by the naturally occurring CXCR4 antagonist EPI-X4 in waldenström’s macroglobulinemia
The influence of various aminoglycoside preparations on bilirubin/albumin binding
Establishment of an ELISA to detect the CXCR4 antagonist hSA (408-423) and characterization of CXCR4 mutants associedet with WHIM syndrome
Antagonist
The novel CXCR4 antagonist POL5551 mobilizes hematopoietic stem and progenitor cells with greater efficiency than Plerixafor
The CXCR4 antagonist POL5551 is equally effective as sirolimus in reducing neointima formation without re-endothelialisation
Albumin
The CXCR4 antagonist plerixafor (AMD3100) promotes proliferation of Ewing sarcoma cell lines in vitro and activates receptor tyrosine kinase signaling
Albumin-Mattpapier
Absence